Publications by authors named "Samir Mody"

Claim this Profile
D
Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy.
Joseph F Dasta, Dominic Pilon, Samir H Mody, Jessica Lopatto, François Laliberté

J Med Econ· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis.
Kathleen Lang, Victoria Federico, Aarti A Patel, Michael Munsell, Winnie W Nelson, Samir H Mody

J Comp Eff Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.
Kathleen Lang, Aarti A Patel, Michael Munsell, Brahim K Bookhart, Samir H Mody

J Thromb Thrombolysis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism.
Aarti A Patel, Kristine Ogden, Samir H Mody, Brahim Bookhart

J Med Econ· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.
Joseph F Dasta, Dominic Pilon, Samir H Mody, Jessica Lopatto, François Laliberté

Thromb Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
Joyce C LaMori, Omar Shoheiber, Samir H Mody, Brahim K Bookhart

Clin Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.
Roxanne Meyer, Anisha M Patel, Stacy K Rattana, Tiffany P Quock, Samir H Mody

Popul Health Manag· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal comorbidities associated with atrial fibrillation.
François Laliberté, Yuliya Moore, Katherine Dea, Joyce C LaMori, Samir H Mody

Springerplus· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
Brahim K Bookhart, Lloyd Haskell, Luke Bamber, Maria Wang, Jeff Schein, Samir H Mody

J Med Econ· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-analysis model for anticoagulant treatment in the hospital setting.
Samir H Mody, Lynn Huynh, Daisy Y Zhuo, Kevin N Tran, Patrick Lefebvre

J Med Econ· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.
Kathleen Lang, Duygu Bozkaya, Aarti A Patel, Brian Macomson, Winnie Nelson, Samir Mody

BMC Health Serv Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis.
Aarti A Patel, Kristine Ogden, Mark Veerman, Samir H Mody, Winnie W Nelson

Popul Health Manag· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of extended duration anticoagulation with rivaroxaban to prevent recurrent venous thromboembolism.
Craig I Coleman, Brendan L Limone, Brahim K Bookhart, Samir H Mody, Edith A Nutescu

Thromb Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician management of moderate-to-severe acute pain: results from the Physicians Partnering Against Pain (P³) study.
Bill H McCarberg, Aarti A Patel, Carmela J Benson, Samir H Mody, Wing Chow

J Opioid Manag· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic impact of acute coronary syndrome on length of stay: an analysis using the Healthcare Cost and Utilization Project (HCUP) databases.
Joyce C LaMori, Omar Shoheiber, Kellie Dudash, Concetta Crivera, Samir H Mody

J Med Econ· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
Patrick Lefebvre, Craig I Coleman, Brahim K Bookhart, Si-Tien Wang, Samir H Mody

J Med Econ· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR.
Andrew Paris, Chris M Kozma, Wing Chow, Anisha M Patel, Samir H Mody

Am Health Drug Benefits· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States.
Nancy Neil, Sanjay Merchant, David Provenzano, Kristine Ogden, Samir H Mody

J Med Econ· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.
Sanjay Merchant, David Provenzano, Samir Mody, Kai Fai Ho, Mila Etropolski

J Opioid Manag· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.
Sanjay Merchant, Les L Noe, Andrew Howe, Steve Duff, Joe Gricar, Samir H Mody

Clin Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy.
Jacqueline Pesa, Roxanne Meyer, Tiffany P Quock, Stacy K Rattana, Samir H Mody

Am Health Drug Benefits· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of comorbidities among patients with atrial fibrillation.
Joyce C LaMori, Samir H Mody, Hillary J Gross, Marco daCosta DiBonaventura, Aarti A Patel

Ther Adv Cardiovasc Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic.
Edith A Nutescu, Adriana Bautista, Weihua Gao, William L Galanter, Glen T Schumock, Samir H Mody

Am J Health Syst Pharm· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment.
Shih-Yin Chen, Julie Vanderpoel, Samir Mody, Winnie W Nelson, Jeffrey Schein

Am J Geriatr Pharmacother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation.
Aarti A Patel, Barb Lennert, Brian Macomson, Winnie W Nelson, Gary M Owens, Samir H Mody

Am Health Drug Benefits· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis